GlassScriptPhysician profile
Hector L Vega
NPI 1669493433
$1,394.47
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,394.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $184.58 | 2021 | |
| Abbvie INC. | $151.24 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $147.88 | 2021 | |
| Esperion Therapeutics, INC. | $132.58 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $124.55 | 2021 | |
| Astellas Pharma US INC | $123.18 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.55 | 2021 | |
| Glaxosmithkline, LLC. | $76.54 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $58.73 | 2021 | |
| Merck Sharp & Dohme LLC | $58.18 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.53 | 2021 | |
| Sanofi-Aventis U.S. LLC | $43.63 | 2021 | |
| Clarus Therapeutics INC. | $35.22 | 2021 | |
| Mylan Specialty L.P. | $27.99 | 2021 | |
| Jazz Pharmaceuticals INC. | $27.28 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $19.41 | 2021 | |
| Sunovion Pharmaceuticals INC. | $17.42 | 2021 | |
| Nestle Healthcare Nutrition INC. | $15.98 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Vega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.